Grace Goldstein

Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs

Simron Singh, Edward M. Wolin, Richard R.P. Warner et al. · Journal of Global Oncology · 2016 · 153 citations · Full text

Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors

Edward M. Wolin, John Leyden, Grace Goldstein et al. · Pancreas · 2017 · 57 citations · Full text

Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals

Simone Leyden, Teodora Kolarova, Catherine Bouvier et al. · International Journal of Cancer · 2019 · 30 citations · Full text

Pivotal phase III COMPOSE trial will compare ¹⁷⁷Lu-edotreotide with best standard of care for well-differentiated aggressive grade 2 and grade 3 gastroenteropancreatic neuroendocrine tumors.

Diane Reidy‐Lagunes, Namrata Vijayvergia, Daniel M. Halperin et al. · Journal of Clinical Oncology · 2022 · 24 citations

Surgical Oncology, Best Standard, Pathology +16

PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly

Dermot O’Toole, Pamela L. Kunz, Susan M. Webb et al. · Advances in Therapy · 2022 · 15 citations · Full text

Endocrine Oncology, Oncology, Latest Devices/formulations +7